Vulnerable Spot On Respiratory Syncytial Virus Protein Could Lead To Vaccine

An atomic-level snapshot of a respiratory syncytial virus (RSV) protein bound to a human antibody represents a leap toward developing a vaccine for a common - and sometimes very serious - childhood disease. The findings, by scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, define the vulnerable shape of a critical RSV component called the fusion glycoprotein. The NIAID scientists determined the fusion glycoprotein's shape as it appears before its interaction with human cells... via Health News from Medical News Today Read More Here..